tibolone has been researched along with estrone sulfate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kloosterboer, HJ; Löfgren, L; Verheul, HA; von Schoultz, B; von Schoulz, E | 1 |
| Blok, LJ; Burger, CW; Hanifi-Moghaddam, P; Kloosterboer, HJ; Verheul, HA | 1 |
2 trial(s) available for tibolone and estrone sulfate
| Article | Year |
|---|---|
Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days.
Topics: Aged; Androstenols; Breast; Breast Neoplasms; Chromatography, Liquid; Double-Blind Method; Estradiol; Estrenes; Estrone; Female; Gas Chromatography-Mass Spectrometry; Humans; Middle Aged; Neoplasm Staging; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators; Tandem Mass Spectrometry; Tissue Distribution | 2007 |
Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
Topics: Aged; Estradiol; Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Myometrium; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators; Tissue Distribution; Uterine Prolapse; Vagina | 2007 |